In this business results are measured by return to shareholders and projected asset/income valuations.
if not for covid MSB has failed miserably and that is why there is no interest by big pharma or the majority of instituitional investors.
that said they might get lucky with covid but i think Eswaran's 1 in 3 probability is pretty close.and they have some good research BUT
translating that into shareholder value is along way off.
https://www.copyright link/rear-window/somebody-tell-mesoblast-we-get-the-message-20200603-p54z13 is a pretty good summary of
what most insitutional investors think about Mesoblasts constant hype.
maybe you are on the MSB hype team. i dont know. i just try to present reality!!
In this business results are measured by return to shareholders...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.055(5.24%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.13 | $1.04 | $6.781M | 6.207M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 43856 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 66000 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |